Sun Pharmaceutical Industries Share Price Today - Live Blog for April 21, 2025

Following a noteworthy 0.06% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,746.00. When it comes to valuation, this stock has a PE ratio of 36.7500, with the industry PE ratio at 33.9840.

Sun Pharmaceutical Industries Ltd witnessed a substantial 0.06% increase in its share price and is currently trading at ₹1,744.75. This remarkable performance has caught the eye of investors.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.06% decline, and it currently trades at ₹1,744.30 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

The stock price of Sun Pharmaceutical Industries Ltd enjoyed a significant 0.06% boost, with the current market value at ₹1,745.30 per share. This surge has not gone unnoticed by investors.

Sun Pharmaceutical Industries Ltd witnessed a -0.31% decrease in its share price, and it is currently trading at ₹1,744.20. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 36.7500, an ROE of 15.9938% and a debt to equity ratio of 0.0372.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.04%, a situation worth noting. At present, the stock is trading at ₹1,748.00. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 36.7500, while the industry PE ratio is 33.9840.

Sun Pharmaceutical Industries Ltd shares experienced a -0.09% reduction, with the current market price at ₹1,749.90. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Demonstrating a commendable 0.06% gain, Sun Pharmaceutical Industries Ltd's share price is currently situated at ₹1,752.00. In terms of valuation, the stock maintains a PE ratio of 36.7500, while the industry PE ratio stands at 33.9840.

Demonstrating a commendable 0.08% gain, Sun Pharmaceutical Industries Ltd's share price is currently situated at ₹1,751.00. In terms of valuation, the stock maintains a PE ratio of 36.7500, while the industry PE ratio stands at 33.9840.

The stock of Sun Pharmaceutical Industries Ltd is facing a -0.28% decline and is currently trading at ₹1,745.80 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Sun Pharmaceutical Industries Ltd's stock has risen by a substantial 0.27%, and as of now, it's trading at ₹1,750.75 per share. This upward trajectory is attracting keen interest from investors.

Sun Pharmaceutical Industries Ltd witnessed a notable 0.03% surge in its share price and is presently trading at ₹1,747.90, captivating the attention of market participants.

In the financial arena, Sun Pharmaceutical Industries Ltd's stock price has increased by 0.01%, with its current market value per share resting at ₹1,747.30. This development highlights the stock's appeal to investors.

After a notable 0.12% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,747.15. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.0372 and an ROE of 15.9938%.

Sun Pharmaceutical Industries Ltd's stock has risen by a substantial 0.10%, and as of now, it's trading at ₹1,743.30 per share. This upward trajectory is attracting keen interest from investors.

Sun Pharmaceutical Industries Ltd experienced a substantial 0.04% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,742.75, making it an appealing option for investors.

The share price of Sun Pharmaceutical Industries Ltd experienced a -0.17% slump and is currently trading at ₹1,742.05. While the stock maintains a PE ratio of 36.7500, the industry PE is 33.9840, raising questions about valuation.

The share price of Sun Pharmaceutical Industries Ltd experienced an impressive 0.20% upswing and is currently trading at ₹1,744.65, indicating strong market sentiment.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.15% decline, and it currently trades at ₹1,740.30 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Demonstrating a commendable 0.10% gain, Sun Pharmaceutical Industries Ltd's share price is currently situated at ₹1,742.80. In terms of valuation, the stock maintains a PE ratio of 36.7500, while the industry PE ratio stands at 33.9840.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.09%, a situation worth noting. At present, the stock is trading at ₹1,740.00. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 36.7500, while the industry PE ratio is 33.9840.

Sun Pharmaceutical Industries Ltd experienced a -0.09% downturn in its share price, and it's currently trading at ₹1,740.00. This situation is generating interest among value investors who are evaluating the stock's potential.

The stock of Sun Pharmaceutical Industries Ltd is facing a -0.06% decline and is currently trading at ₹1,745.95 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.06%, a situation worth noting. At present, the stock is trading at ₹1,745.95. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 36.7500, while the industry PE ratio is 33.9840.

After a notable 0.40% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,747.00. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.0372 and an ROE of 15.9938%.

Sun Pharmaceutical Industries Ltd's share price has dropped by -1.97%, a development that warrants careful analysis. Presently trading at ₹1,739.00, investors are assessing whether this presents an opportunity or a risk.